Derek J. Maetzold - Pres. & Chief Exec. Officer, Director at Castle Biosciences Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
Pres. & Chief Exec. Officer, Director
Stock Symbol
CSTL on Nasdaq
Industry
Services-Medical Laboratories
All Insider Reports
All Insider Reports

Derek J. Maetzold - trading volume in the past year for Castle Biosciences Inc

Holdings reported by Derek J. Maetzold for Castle Biosciences Inc

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 123K $2.48M $20.22 Apr 8, 2025 By DJM Grantor Retained Annuity Trust No. 5
Restricted Stock Units 93.3K $1.95M $20.86 Mar 4, 2025 Direct Common Stock
Performance-Based Stock Unit 67K $1.8M $26.83 Aug 9, 2024 Direct Common Stock
Common Stock 75.9K $1.53M $20.22 Apr 9, 2025 Direct
Common Stock 63K $1.27M $20.22 Apr 9, 2025 By The Maetzold Descendants 2020 Trust
Common Stock 53.6K $1.08M $20.22 Apr 9, 2025 By Derek Maetzold 2020 Irrevocable Trust
Common Stock 26.1K $528K $20.22 Apr 8, 2025 By DJM Grantor Retained Annuity Trust No. 6
Common Stock 4.44K $89.8K $20.22 Apr 9, 2025 By The Maetzold 2018 Remainder Trust FBO Emily Carol Kirk
Common Stock 4.44K $89.8K $20.22 Apr 9, 2025 By The Maetzold 2018 Remainder Trust FBO Hannah Elizabeth Maetzold
Common Stock 4.44K $89.8K $20.22 Apr 9, 2025 By The Maetzold 2018 Remainder Trust FBO John Derek Maetzold
Common Stock 4.44K $89.8K $20.22 Apr 9, 2025 By The Maetzold 2018 Remainder Trust FBO Peter Douglas Maetzold

Transactions reported by Derek J. Maetzold for Castle Biosciences Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.